Coreceptors: implications for HIV pathogenesis and therapy.
Moore
J P
JP
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY 10016, USA. John_Moore@adarc.org
D016915:AIDS Vaccines; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism / Q000821:virology; D018925:Chemokines / Q000627:therapeutic use; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D015658:HIV Infections / Q000628:therapy / Q000821:virology*; D015497:HIV-1 / Q000378:metabolism* / Q000472:pathogenicity; D006801:Humans; D008264:Macrophages / Q000378:metabolism / Q000821:virology; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D018121:Receptors, Cytokine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015728:Receptors, HIV / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014774:Virulence
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D018925:Chemokines; D015699:HIV Envelope Protein gp120; D008565:Membrane Proteins; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D018121:Receptors, Cytokine; D015728:Receptors, HIV